Tellgen Corporation’s Post

View organization page for Tellgen Corporation, graphic

930 followers

Multiplexing is transforming the world of in vitro diagnostics, enabling the concurrent measurement of multiple analytes from a single sample. This maximizes the power of precious clinical samples. At Tellgen, we are pioneering highly multiplexed immunoassays that can quantitatively detect up to 100 proteins in one test. Our advanced multiplex technology is powered by: Proprietary microbead panels with high-capacity encoding Precision fluidics for controlled bead movement Multi-laser optics for simultaneous signal detection Multiplexing provides game-changing advantages: Higher throughput and efficiency Comprehensive biomarker profiling Superior clinical sensitivity and accuracy Better utilization of samples and reagents Our robust multiplex immunoassay menu covers oncology, autoimmunity, infectious disease and more. The automated TESMI system allows accurate, high-speed testing for improved patient management. Let us show you how multiplexing can transform your clinical diagnostics. Get in touch today! #multiplex #immunoassay #biomarkers #diagnostics #efficiency

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics